Pluri Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PLUR.TA research report →
Price Chart
About the company
Based in Haifa, Israel, and established in 2001, Pluri Inc. is a biotechnology company dedicated to advancing placenta-derived cell therapies. Its primary goal is to address a spectrum of health issues, including inflammatory conditions, muscle damage, and blood disorders.
- CEO
- Yaacov Yanay
- IPO
- 2011
- Employees
- 127
- HQ
- Haifa, HA, IL
Get TickerSpark's AI analysis on PLUR.TA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $56.40M
- P/E
- -0.62
- PEG
- -0.02
- P/S
- 17.70
- P/B
- -0.96
- EV/EBITDA
- -1.89
- Div Yield
- 0.00%
- Gross Margin
- 19.00%
- Op Margin
- -2412.14%
- Net Margin
- -2424.75%
- ROE
- 203.55%
- ROIC
- -117.79%
Latest fiscal year · YoY change
- Revenue
- $1.34M+309.8%
- Gross Profit
- $654.00K+103.1%
- Op Income
- $-22,176,000
- Net Income
- $-22,583,000-8.1%
- EPS
- $-3.56+10.8%
- OCF Growth
- -1.1%
- FCF Growth
- -8.1%
- 52W High
- $1848.00
- 52W Low
- $465.00
- 50D MA
- $573.25
- 200D MA
- $917.20
- Beta
- 0.68
- RSI (14)
- 49
- Avg Volume
- 8.86K
No earnings-call transcripts are available for PLUR.TA yet.
- Free Float
- 58.0%
- Shares Outstanding
- 10.65M
- Float Shares
- 6.17M
Our PLUR.TA coverage
Recent articles, reports, and earnings notes.
No research on PLUR.TA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PLUR.TA report →